Europe Squalene Market Projected To Reach USD 10.36 Billion By 2028
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhZGnLy2SMzz5U0FdKvAkqdlyXmwypYOTvaDyiGBbkcO-PEzZQk9hKq47iEaJjYZyN_aPE_oSYw_g7JIod-Pg6HAGWqEbxyVuz7EbNxu3tQ9aJ4YeYVGnoKDcNwVFMQsDdd7rCySmXRzhYF/s320/Europe+Squalene+Market.png)
San Francisco, 21 Sep 2021: The Report Europe Squalene Market Size, Share & Trends Analysis Report By Source (Animal, Plant, Synthetic), By End Use (Pharmaceuticals, Personal Care & Cosmetics, Nutraceuticals, Food & Beverages), By Country, And Segment Forecasts, 2021 - 2030 The Europe squalene market size is expected to reach USD 99.12 million by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.6% from 2021 to 2030. Increasing usage of squalene in pharmaceutical products as an adjuvant for immune enhancement is one of the major factors driving the demand. Squalene plays a vital role in certain additives, namely adjuvants that boost the immune response of the body through the active ingredients present in vaccines. In vaccines, it is used as an oil-in-water emulsion form, coupled with adjuvants and stimulants of the immune system. It plays the role of surfactant, thus increasing the response of the vaccines. As per t